160 related articles for article (PubMed ID: 2177606)
1. Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate.
Gandara DR; Wiebe VJ; Perez EA; Makuch RW; DeGregorio MW
Crit Rev Oncol Hematol; 1990; 10(4):353-65. PubMed ID: 2177606
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity.
Gandara DR; Perez EA; Weibe V; De Gregorio MW
Semin Oncol; 1991 Feb; 18(1 Suppl 3):49-55. PubMed ID: 1848372
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin nephrotoxicity: diethyldithiocarbamate, WR2721, or just water?
Cvitkovic E; Hayes DM; Golbey RB; Krakoff IH
J Clin Oncol; 1991 Apr; 9(4):707-9. PubMed ID: 1648600
[No Abstract] [Full Text] [Related]
4. WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
Treskes M; van der Vijgh WJ
Cancer Chemother Pharmacol; 1993; 33(2):93-106. PubMed ID: 8261581
[TBL] [Abstract][Full Text] [Related]
5. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
[TBL] [Abstract][Full Text] [Related]
6. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
Church MW; Kaltenbach JA; Blakley BW; Burgio DL
Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions to reduce platinum-induced toxicity.
Tognella S
Cancer Treat Rev; 1990 Sep; 17(2-3):139-42. PubMed ID: 2176930
[No Abstract] [Full Text] [Related]
8. Modification of cisplatin toxicity with diethyldithiocarbamate.
Berry JM; Jacobs C; Sikic B; Halsey J; Borch RF
J Clin Oncol; 1990 Sep; 8(9):1585-90. PubMed ID: 2167955
[TBL] [Abstract][Full Text] [Related]
9. Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate.
Markman M; D'Acquisto R; Iannotti N; Kris M; Hakes T; Bajorin D; Bosl G; Reichman B; Casper E; Magill G
J Cancer Res Clin Oncol; 1991; 117(2):151-5. PubMed ID: 2007612
[TBL] [Abstract][Full Text] [Related]
10. High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observations.
DeGregorio MW; Gandara DR; Holleran WM; Perez EA; King CC; Wold HG; Montine TJ; Borch RF
Cancer Chemother Pharmacol; 1989; 23(5):276-8. PubMed ID: 2539912
[TBL] [Abstract][Full Text] [Related]
11. Methods of reduction of cisplatin nephrotoxicity.
Walker EM; Gale GR
Ann Clin Lab Sci; 1981; 11(5):397-410. PubMed ID: 6277229
[TBL] [Abstract][Full Text] [Related]
12. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
Freyer DR; Brock P; Knight K; Reaman G; Cabral S; Robinson PD; Sung L
Lancet Child Adolesc Health; 2019 Aug; 3(8):578-584. PubMed ID: 31160205
[TBL] [Abstract][Full Text] [Related]
13. [The pharmacokinetics and clinical toxicities following intraperitoneal infusion of cis-diamminedichloroplatinum (II) with simultaneous sodium thiosulfate rescue in patients with ovarian cancer].
Takizawa K; Ino Y; Isono T; Sato M; Iguchi T; Takeda Y
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1483-90. PubMed ID: 3183457
[No Abstract] [Full Text] [Related]
14. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
Treskes M; Nijtmans LG; Fichtinger-Schepman AM; van der Vijgh WJ
Biochem Pharmacol; 1992 Mar; 43(5):1013-9. PubMed ID: 1313234
[TBL] [Abstract][Full Text] [Related]
15. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy].
Shibuya M; Hirosawa A; Niitani H
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664
[TBL] [Abstract][Full Text] [Related]
16. Newer insights into cisplatin nephrotoxicity.
Anand AJ; Bashey B
Ann Pharmacother; 1993 Dec; 27(12):1519-25. PubMed ID: 8305788
[TBL] [Abstract][Full Text] [Related]
17. Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol).
Schuchter LM
Eur J Cancer; 1996; 32A Suppl 4():S40-2. PubMed ID: 8976821
[TBL] [Abstract][Full Text] [Related]
18. [Effect of sodium thiosulfate on the anti-tumor effect and nephrotoxicity of CDDP in human gastric cancer].
Saito D; Fujii T; Yoshida S; Ohkura H; Oguro Y
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):959-63. PubMed ID: 2188616
[No Abstract] [Full Text] [Related]
19. Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy.
Goel R; Andrews PA; Pfeifle CE; Abramson IS; Kirmani S; Howell SB
Eur J Cancer; 1990 Jan; 26(1):21-7. PubMed ID: 2156545
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin overdose: toxicities and management.
Tsang RY; Al-Fayea T; Au HJ
Drug Saf; 2009; 32(12):1109-22. PubMed ID: 19916578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
